Advertisement
Screener

Deciphera Pharmaceuticals, Inc. Patents: Applications Pending, 2024

Deciphera Pharmaceuticals, Inc. Patent Applications Pending

36 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-12-24: Application 19001282; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Docketed New Case - Ready for Examination.
  • 2024-12-20: Application 63737143; Invention CDK INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
  • 2024-12-20: Application 63736980; Invention FORMULATIONS OF ULK INHIBITORS; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
  • 2024-12-18: Application PCTUS2024060773; Invention DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOF; Applicant DECIPHERA PHARMACEUTICALS, LLC; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2024-12-2419001282RAF KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250250235A1
Daniel L. Flynn
Yu Mi Ahn
Lakshminarayana Vogeti
Bertrand Le Bourdonnec
United States
United States
United States
United States
CENTRAL, DOCKET
2024-12-2063737143CDK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Andrew M. Harned
Yu Mi Ahn
Daniel L. Flynn
Bertrand Le Bourdonnec
Hunter Picard
Saqib Faisal
United States
United States
United States
United States
United States
United States
2024-12-2063736980FORMULATIONS OF ULK INHIBITORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Ehab Hamed
Michael T. Kennedy
United States
United States
2024-12-18PCTUS2024060773DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
BRYAN D. SMITH
STACIE BULFER
JEFFERY ZWICKER
SALIM JAVED
CHASE CRAWLEY
United States
United States
United States
United States
United States
United States
United States
United States
2024-12-1818985885DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250206729A1
Yu Mi Ahn
Daniel L. Flynn
Bertrand Le Bourdonnec
Bryan D. Smith
Stacie Bulfer
Jeffery Zwicker
Salim Javed
Chase Crawley
United States
United States
United States
United States
United States
United States
United States
United States
HUI, SAN MING R
2024-12-13PCTUS2024060067FORMULATIONS OF A CSF-1R INHIBITORDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
EHAB HAMED
DAVID P. PLEYNET
United States
United States
2024-12-13PCTUS2024060064VPS34 INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
KRISTEN L. STUEVEN
JEFFERY ZWICKER
YU MI AHN
DANIEL L. FLYNN
United States
United States
United States
United States
2024-12-1318980426FORMULATIONS OF A CSF-1R INHIBITORDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250195487A1
Ehab Hamed
David P. Pleynet
United States
United States
BRAUN, MADELINE E
2024-12-1318980378VPS34 INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250236609A1
Kristen L. Stueven
Jeffery Zwicker
Yu Mi Ahn
Daniel L. Flynn
United States
United States
United States
United States
NESTOR, DONNA MICHELLE
2024-12-06PCTUS2024058998FORMULATIONS OF VIMSELTINIBDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
EHAB HAMED
United States
2024-12-06PCTUS2024058988SOLID STATE FORMS OF A KINASE INHIBITORDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
ELENA KOSTIK
MICHAEL D. KAUFMAN
United States
United States
2024-12-0618971846FORMULATIONS OF VIMSELTINIBDeciphera Pharmaceuticals, LLCNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20250205161A1
Ehab Hamed
United States
KWON, JOHN SEUNGJAI
2024-12-0618971800SOLID FORMS OF AN ULK INHIBITORDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250206720A1
Elena Kostik
Michael D. Kaufman
United States
United States
SEITZ, ANTHONY JOSEPH
2024-11-2663725057ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Yu Mi Ahn
Daniel L. Flynn
Andrew M. Harned
Justin T. Proto
Hanumaiah Telikepalli
United States
United States
United States
United States
United States
United States
2024-11-0663716893ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Daniel L. Flynn
Andrew M. Harned
Justin T. Proto
Saqib Faisal
United States
United States
United States
United States
United States
2024-11-0163715179ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Yu Mi Ahn
Daniel L. Flynn
Andrew M. Harned
Saqib Faisal
Hunter Picard
United States
United States
United States
United States
United States
United States
2024-10-28PCTUS2024053261METHODS OF TREATING TENOSYNOVIAL GIANT CELL TUMORSDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
RODRIGO RUIZ SOTO
MAITREYI G. SHARMA
United States
United States
2024-08-2618815054COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSISDeciphera Pharmaceuticals, LLCDocketed New Case - Ready for ExaminationUS20250090506A1
Daniel L. Flynn
Bryan D. Smith
Anu Gupta
United States
United States
United States
CHONG, YONG SOO
2024-08-1663683741METHODS OF TREATING TENOSYNOVIAL GIANT CELL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Maitreyi G. Sharma
United States
United States
2024-07-1118770318PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCNon Final Action MailedUS20250084073A1
Daniel L. Flynn
Yu Mi Ahn
Timothy Caldwell
Lakshminarayana Vogeti
United States
United States
United States
United States
KIFLE, BRUCK
2024-06-12PCTUS2024033530DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
LAKSHMINARAYANA VOGETI
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
BRYAN D. SMITH
STACIE BULFER
GREGORY DEAN PLOWMAN
SALIM JAVED
United States
United States
United States
United States
United States
United States
United States
United States
2024-06-12PCTUS2024033528DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USEDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
BRYAN D. SMITH
STACIE BULFER
JEFFERY ZWICKER
SALIM JAVED
CHASE CRAWLEY
United States
United States
United States
United States
United States
United States
United States
United States
2024-06-12PCTUS2024033525DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
YU MI AHN
LAKSHMINARAYANA VOGETI
DANIEL L. FLYNN
BERTRAND LE BOURDONNEC
BRYAN D. SMITH
STACIE BULFER
SALIM JAVED
CHASE CRAWLEY
United States
United States
United States
United States
United States
United States
United States
United States
2024-05-29PCTUS2024031438GCN2 AND PERK KINASE MODULATORS AND METHODS OF USE THEREOFDECIPHERA PHARMACEUTICALS, LLCRO PROCESSING COMPLETED-PLACED IN STORAGE
JEFFERY ZWICKER
SALIM JAVED
PATRICK KEARNEY
YU MI AHN
BERTRAND LE BOURDONNEC
DANIEL L. FLYNN
United States
United States
United States
United States
United States
United States
2024-05-2163650146METHODS OF TREATING TENOSYNOVIAL GIANT CELL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Maitreyi G. Sharma
United States
United States
2024-05-2163650144SOLID STATE FORMS OF A KINASE INHIBITORDeciphera Pharmaceuticals, LLCProvisional Application Expired
Elena Kostik
Michael D. Kaufman
United States
United States
2024-05-0163641028CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
2024-05-0163641022PROCESSES OF MAKING CSF-1R INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Elena Kostik
Ann Gelormini
Michael D. Kaufman
United States
United States
United States
2024-04-0463574671METHODS OF TREATING TENOSYNOVIAL GIANT CELL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Maitreyi G. Sharma
United States
United States
2024-02-1218683078COMBINATION THERAPY USING VPS34 INHIBITORSDeciphera Pharmaceuticals, LLCNon Final Action MailedUS20250127790A1
Yasmin Yu
Martin Andersson
Daniel L. Flynn
Madhumita Bogdan
Sweden
Sweden
United States
United States
PECKHAM, RICHARD GRANT
2024-02-0263549108ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Daniel L. Flynn
Andrew M. Harned
Justin T. Proto
Saqib Faisal
United States
United States
United States
United States
United States
2024-02-0263549102ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Yu Mi Ahn
Daniel L. Flynn
Andrew M. Harned
Justin T. Proto
Hanumaiah Telikepalli
United States
United States
United States
United States
United States
United States
2024-02-0263549095ULK INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen L. Stueven
Yu Mi Ahn
Daniel L. Flynn
Andrew M. Harned
Saquib Faisal
Hunter Picard
United States
United States
United States
United States
United States
United States
2024-01-1963622689METHODS OF TREATING TENOSYNOVIAL GIANT CELL TUMORSDeciphera Pharmaceuticals, LLCProvisional Application Expired
Rodrigo Ruiz Soto
Maitreyi G. Sharma
United States
United States
2024-01-1963622680VPS34 INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCProvisional Application Expired
Kristen Stoltz
Jeffery Zwicker
Yu Mi Ahn
Daniel L. Flynn
United States
United States
United States
United States
2024-01-1018408956GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOFDeciphera Pharmaceuticals, LLCNotice of Allowance Mailed -- Application Received in Office of PublicationsUS20240376058A1
Daniel L. Flynn
Patrick Kearney
Jeffery Zwicker
Gada Al-Ani
Salim Javed
Yu Mi Ahn
Kristen Stoltz
Bertrand Le Bourdonnec
United States
United States
United States
United States
United States
United States
United States
United States
MCDOWELL, BRIAN E